Skip to content
healthcare.dev

IMULDOSA

NDC 69448-019, ustekinumab-srlf, injection, from Accord BioPharma Inc..

Product NDC
69448-019
Status
Listed
Labeler
Accord BioPharma Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761364
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69448-019 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB-SRLF130 mg/26mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
69448-019-26694480019261 VIAL, SINGLE-USE in 1 CARTON (69448-019-26) / 26 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2539a6cf-0fe5-1565-e063-6294a90a3618
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69448-019

Use it

Look up 69448-019 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69448-019 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69448-019. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.